Gen Re Releases 2024 U.S. Individual Life Accelerated Underwriting Survey Results

Accelerated Underwriting continues to evolve in 2024.

STAMFORD, Conn.--(BUSINESS WIRE)--Gen Re has released results of the 2024 U.S. Individual Life Accelerated Underwriting Survey. This comprehensive survey covers topics including: throughput rates, sources of underwriting evidence, mortality experience, and pre-/post-issue auditing tools.

Thirty-eight Individual Life insurance carriers participated in this study. Gen Re recognizes that carriers may be at varying stages of implementation with their Accelerated Underwriting workflow.

Key observations of the survey include:

• Eighty-two percent of companies have either a fully implemented or partially implemented workflow.
• Top AU workflow goals include reducing time to issue (53%), meeting consumer expectations (53%), and managing mortality slippage (44%).
• Almost all (94%) companies offer a Term Life product through their AU workflow. Other Individual Life products eligible for AU include Whole Life (56%) and Universal Life (63%).
• Sixty-three percent of companies use random holdouts as a control measure throughout their AU workflow. Other common controls in place include post-issue APS (47%), and post-issue EHR (41%).
• Fifty-six percent of companies estimate mortality slippage associated with their AU program through random holdouts. Thirty-eight percent are monitoring early claims experience, 34% utilize post-issue APS, and 16% utilize retrospective studies.

The U.S. Individual Life Accelerated Underwriting Survey is an annual survey produced by Gen Re, with the full results available only to participating companies. A summary report is available online at genre.com/lhsurveys.

About Gen Re

Gen Re, a Berkshire Hathaway Company, is one of the leading Life/Health and Property/Casualty reinsurers in the world. Our North American Life/Health reinsurance company, General Re Life Corporation, has superior financial strength ratings among Life and Health reinsurers. Gen Re delivers customized reinsurance programs and risk management solutions for the Life, Medicare Supplement, Critical Illness, and Individual Disability Income markets. Through our research, we also offer valuable information and insights. www.genre.com